Quick Answer
OKYO Pharma Ltd reported Total Assets of $3.68 million for the year ending 2025.
- OKYO Pharma Ltd showed an increase of +138.6% in Total Assets from 2024 to 2025.
- This data is from OKYO Pharma Ltd's annual report (Form 10-K), filed with the SEC on July 18, 2025.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2021 to 2025), OKYO Pharma Ltd's Total Assets has declined by 48.1%.
- Historical annual values: Fiscal year 2025: $3.68 million | Fiscal year 2024: $1.54 million | Fiscal year 2023: $5.20 million | Fiscal year 2022: $4.30 million | Fiscal year 2021: $7.09 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: